[ Price : $8.95]
FDA says it is requiring 16 manufacturers of Class 2 spinal dynamic stabilization systems to conduct postmarketing safety studies.[ Price : $8.95]
Nearly six weeks after Pfizer agreed to pay $2.3 billion to resolve illegal promotion charges involving several drug products, the...[ Price : $8.95]
An FDA advisory panel unanimously votes to recommend approval for GlaxoSmithKlines Votrient (pazopanib) for patients with advanced...[ Price : $8.95]
FDAs Oncologic Drugs Advisory Committee votes 6-4 to recommend approval of Schering-Ploughs Pegintron as adjuvant treatment for pa...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on developing drugs for treating Heliobacter pylori-associated duodenal ulc...[ Price : $8.95]
FDA Webview editor Jim Dickinson reviews FDAs accelerating record of bureaucratic secrecy against new transparency efforts and con...[ Price : $8.95]
FDA issues a tentative approval for an Impax Laboratories ANDA for a generic version of Boehringer Ingelheim Pharmaceuticals Floma...[ Price : $8.95]
GlaxoSmithKline files a supplemental NDA for Avodart (dutasteride) and a claim for prostate cancer risk reduction among men at inc...